pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$ADPTAdaptive Biotechnologies Corp

$ADPT24.77+0.12%
Seattle, WA, USupdated 6h ago
SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Preclinical: 1
1Preclinical
Preclinical
Second Shared Cell Therapy
Unspecified Cancer

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

earnings (1)
Jul 29, 2026
earnings
$ADPT24.77+0.12%
20d ago
Adaptive Biotechnologies Corp earnings
Adaptive Biotechnologies Corp
→
view all catalysts →

Insider activity

source: SEC Form 4

open-market buys + sells

  • Apr 24, 26SELLRUBINSTEIN JULIE· President and COO19,060 sh @ $14.02−$267K↗
  • Apr 23, 26SELLRUBINSTEIN JULIE· President and COO19,060 sh @ $13.74−$262K↗
  • Apr 22, 26SELLRUBINSTEIN JULIE· President and COO19,060 sh @ $14.13−$269K↗
  • Apr 21, 26SELLRUBINSTEIN JULIE· President and COO30,941 sh @ $14.66−$454K↗
  • Apr 20, 26SELLRUBINSTEIN JULIE· President and COO19,060 sh @ $14.55−$277K↗
  • Apr 17, 26SELLRUBINSTEIN JULIE· President and COO19,060 sh @ $14.57−$278K↗
  • Apr 16, 26SELLRUBINSTEIN JULIE· President and COO19,060 sh @ $14.18−$270K↗
  • Apr 15, 26SELLRUBINSTEIN JULIE· President and COO19,060 sh @ $14.61−$278K↗
  • Apr 14, 26SELLRUBINSTEIN JULIE· President and COO19,060 sh @ $14.56−$278K↗
  • Apr 13, 26SELLRUBINSTEIN JULIE· President and COO15,722 sh @ $12.95−$204K↗
  • Apr 13, 26SELLRUBINSTEIN JULIE· President and COO3,338 sh @ $14.08−$47K↗
  • Apr 10, 26SELLRUBINSTEIN JULIE· President and COO18,660 sh @ $12.75−$238K↗
  • Apr 10, 26SELLRUBINSTEIN JULIE· President and COO400 sh @ $13.48−$5K↗
  • Apr 9, 26SELLRUBINSTEIN JULIE· President and COO16,960 sh @ $13.79−$234K↗
  • Apr 9, 26SELLRUBINSTEIN JULIE· President and COO2,100 sh @ $14.44−$30K↗
  • Apr 8, 26SELLROBINS CHAD M· CEO and Chairman37,263 sh @ $15.19−$566K↗
  • Apr 8, 26SELLRUBINSTEIN JULIE· President and COO30,841 sh @ $14.83−$457K↗
  • Apr 8, 26SELLLO FRANCIS· Chief People Officer22,564 sh @ $15.07−$340K↗
  • Apr 8, 26SELLROBINS HARLAN S· Chief Scientific Officer10,000 sh @ $14.85−$149K↗
  • Apr 8, 26SELLRUBINSTEIN JULIE· President and COO100 sh @ $15.48−$2K↗
🐶 Hiring Signal
No open roles indexed yet — view Adaptive Biotechnologies Corp jobs →

News

  • Lilly buys another pain biotech; FDA sets decision for once-weekly PrEP pill
    Plus, news about Merck, MultiValent Biotherapies, Alvotech, enGene, Mirum, and Adaptive Biotechnologies. 💸 Eli Lilly acquires another pain biotech: The Indianapolis pharma giant has made its 11th…
    endpoints · 2mo ago
identifiers
ticker
$ADPT
SEC CIK
0001478320
country
US
source
sec_tickers
top tags
Oncology1
mentioned in
1news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 18m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?